Cloudy dialysate and pseudomembranous colitis in a patient on CAPD.
Sakao
Y
Y
First Department of Medicine Division of Blood Purification Hamamatsu University School of Medicine, Hamamatsu Department of Internal Medicine Fujinomiya City General Hospital, Fujinomiya Shizuoka, Japan.
Kato
A
A
Sugiura
T
T
Fujikura
T
T
Misaki
T
T
Tsuji
T
T
Sakakima
M
M
Yasuda
H
H
Fujigaki
Y
Y
Hishida
A
A
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D002097:C-Reactive Protein / Q000032:analysis; D002442:Ceftazidime / Q000009:adverse effects; D015897:Comorbidity; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced / Q000175:diagnosis* / Q000453:epidemiology*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000453:epidemiology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory
D000900:Anti-Bacterial Agents; D002097:C-Reactive Protein; D002442:Ceftazidime